Paper28220118
Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.
Mizrahy S and 4 others. Front Immunol, 2017. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles. Papers, record 28220118. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28220118
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23113570 | Anti-tumour strategies aiming to target tumour-associated macrophages. | Immunology | 2013 | https://conductscience.org/library/papers/23113570 | PubMed |
| 2 | 21576818 | Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21576818 | PubMed |
| 3 | 12604051 | Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. | J Liposome Res | 2002 | https://conductscience.org/library/papers/12604051 | PubMed |
| 4 | 10688625 | Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. | J Pharmacol Exp Ther | 2000 | https://conductscience.org/library/papers/10688625 | PubMed |
| 5 | 25413851 | siRNA nanoparticles: the future of RNAi therapeutics for oncology? | Nanomedicine (Lond) | 2014 | https://conductscience.org/library/papers/25413851 | PubMed |
| 6 | 22437869 | Combining immunotherapy and targeted therapies in cancer treatment. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22437869 | PubMed |
| 7 | 21983520 | Therapeutic siRNA silencing in inflammatory monocytes in mice. | Nat Biotechnol | 2011 | https://conductscience.org/library/papers/21983520 | PubMed |
| 8 | 8080272 | Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. | Arch Biochem Biophys | 1994 | https://conductscience.org/library/papers/8080272 | PubMed |
| 9 | 23774794 | Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis. | Mol Ther | 2013 | https://conductscience.org/library/papers/23774794 | PubMed |
| 10 | 19632178 | CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. | Cell | 2009 | https://conductscience.org/library/papers/19632178 | PubMed |
| 11 | 18654426 | Nanocarriers as an emerging platform for cancer therapy. | Nat Nanotechnol | 2007 | https://conductscience.org/library/papers/18654426 | PubMed |
| 12 | 27235608 | Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach. | Cancer Lett | 2016 | https://conductscience.org/library/papers/27235608 | PubMed |
| 13 | 17873867 | Exploiting lymphatic transport and complement activation in nanoparticle vaccines. | Nat Biotechnol | 2007 | https://conductscience.org/library/papers/17873867 | PubMed |
| 14 | 17875754 | Transforming growth factor-beta and the immune response: implications for anticancer therapy. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17875754 | PubMed |
| 15 | 25022906 | Non-viral vectors for gene-based therapy. | Nat Rev Genet | 2014 | https://conductscience.org/library/papers/25022906 | PubMed |
| 16 | 27775706 | Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. | Nat Med | 2016 | https://conductscience.org/library/papers/27775706 | PubMed |
| 17 | 25287120 | Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/25287120 | PubMed |
| 18 | 21336265 | Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. | Nat Mater | 2011 | https://conductscience.org/library/papers/21336265 | PubMed |
| 19 | 25558928 | Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles. | ACS Nano | 2015 | https://conductscience.org/library/papers/25558928 | PubMed |
| 20 | 17065229 | Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production. | FASEB J | 2006 | https://conductscience.org/library/papers/17065229 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40860882 | Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40860882 | PubMed |
| 40746220 | Physicochemical Characterization, Drug Release, Stability, and Cytotoxicity of Cross-Linked Curdlan-Based Nanosponges for α-Amyrin and Higenamine Delivery. | Turk J Pharm Sci | 2025 | https://conductscience.org/library/papers/40746220 | PubMed |
| 40379943 | Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40379943 | PubMed |
| 40124335 | For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40124335 | PubMed |
| 37289328 | Adipocyte-derived extracellular vesicles: bridging the communications between obesity and tumor microenvironment. | Discov Oncol | 2023 | https://conductscience.org/library/papers/37289328 | PubMed |
| 36012619 | Lipid Nanoparticles: Promising Treatment Approach for Parkinson's Disease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012619 | PubMed |
| 34063088 | Nanotechnology in Bladder Cancer: Diagnosis and Treatment. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34063088 | PubMed |
| 32440473 | Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer. | Adv Sci (Weinh) | 2020 | https://conductscience.org/library/papers/32440473 | PubMed |
| 32210954 | Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy. | Front Immunol | 2020 | https://conductscience.org/library/papers/32210954 | PubMed |
| 32172351 | Immune cell engineering: opportunities in lung cancer therapeutics. | Drug Deliv Transl Res | 2020 | https://conductscience.org/library/papers/32172351 | PubMed |
| 31218707 | Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines. | Electrophoresis | 2019 | https://conductscience.org/library/papers/31218707 | PubMed |
| 30926812 | Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma. | Nat Commun | 2019 | https://conductscience.org/library/papers/30926812 | PubMed |
| 30863514 | Tetraspanin-decorated extracellular vesicle-mimetics as a novel adaptable reference material. | J Extracell Vesicles | 2019 | https://conductscience.org/library/papers/30863514 | PubMed |
| 29670528 | Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29670528 | PubMed |
| 29391232 | Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment. | J Control Release | 2018 | https://conductscience.org/library/papers/29391232 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28220118
GET https://conductscience.org/api/papers/v1/28220118/references?page=2